The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19

Viral Infections, Non-HIV

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China

Ann Oncol.

Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, Jia P, Guan HQ, Peng L, Chen Y, Peng P, Zhang P, Chu Q, Shen Q, Wang Y, Xu SY, Zhao JP, Zhou M

doi: 10.1016/j.annonc.2020.03.296.

Viral Infections, Non-HIV

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

JAMA Intern Med.

Liang W, Liang H, Ou L, Chen B, Chen A, Li C, Li Y, Guan W, Sang L, Lu J, Xu Y, Chen G, Guo H, Guo J, Chen Z, Zhao Y, Li S, Zhang N, Zhong N, He J, China Medical Treatment Expert Group for COVID-19.

doi: 10.1001/jamainternmed.2020.2033.

Viral Infections, Non-HIV

Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines

Swiss Med Wkly.

Fontana P, Casini A, Robert-Ebadi H, Glauser F, Righini M, Blondon M

doi: 10.4414/smw.2020.20301.

Viral Infections, Non-HIV

The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis

Hematol Oncol Stem Cell Ther.

ElGohary GM, Hashmi S, Styczynski J, Kharfan-Dabaja MA, Alblooshi RM, de la Cámara R, Mohmed S, Alshaibani A, Cesaro S, Abd El-Aziz N, Almaghrabi R, Gergis U, Majhail NS, El-Gohary Y, Chemaly RF, Aljurf M, El Fakih R

doi: 10.1016/j.hemonc.2020.07.005.

Viral Infections, Non-HIV

Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19

Ann Intern Med

Wongvibulsin S, Garibaldi BT, Antar AAR, Wen J, Wang MC, Gupta A, Bollinger R, Xu Y, Wang K, Betz JF, Muschelli J, Bandeen-Roche K, Zeger SL, Robinson ML

doi: 10.7326/M20-6754

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Viral Infections, Non-HIV

Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis

Int J Cancer.

Tian Y, Qiu X, Wang C, Zhao J, Jiang X, Niu W, Huang J, Zhang F

doi: 10.1002/ijc.33213.

Viral Infections, Non-HIV

GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain's COVID-19 Pandemic

Oncologist.

Martin M, Guerrero-Zotano A, Montero Á, Jara C, Filipovich E, Rojo F, Moreno F, García Sáenz JÁ, Alés JE, Chacón JI, Cruz J, Gimenez J, Cruz-Merino L, Algara M, Santisteban M, Tarruella SL, GEICAM Spanish Breast Cancer Group Steering Committee.

doi: 10.1634/theoncologist.2020-0363.

Viral Infections, Non-HIV

Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19

Metabolism

Calvisi SL, Ramirez GA, Scavini M, Da Prat V, Di Lucca G, Laurenzi A, Gallina G, Cavallo L, Borio G, Farolfi F, Pascali M, Castellani J, Lampasona V, D'Angelo A, Landoni G, Ciceri F, Querini PR, Tresoldi M, Piemonti L

doi: 10.1016/j.metabol.2021.154845

Related content

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines

The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis

Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Cancer associates with risk and severe events of COVID-19: A systematic review and meta-analysis

GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain's COVID-19 Pandemic

Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19